Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01CA248216 | U.S. NIH Grant/Contract | View source | |
| NCI-2021-09416 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 2020-1142 | Other Identifier | M D Anderson Cancer Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.
PRIMARY OBJECTIVES:
I. To determine the impact of addressing individual and system levels of influence on HPV vaccination initiation and completion rates.
II. To gain insight into mechanisms of the intervention's efficacy, individual differences, and implementation of the intervention using mixed methods.
OUTLINE: Participants are randomized to 1 of 6 groups.
GROUP I: Participants receive standard Centers for Disease Control and Prevention (CDC) information about HPV vaccination.
GROUP II: Participants receive video narratives about HPV vaccination.
GROUP III: Participants receive written narratives about HPV vaccination.
GROUP IV: Participants receive enhanced access to vaccination and standard CDC information about HPV vaccination.
GROUP V: Participants receive enhanced access to vaccination and video narratives about HPV vaccination.
GROUP VI: Participants receive enhanced access to vaccination and written narratives about HPV vaccination.
After completion of study, participants are followed up at 3 and 9 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I (standard CDC information) | Active Comparator | Participants receive standard CDC information about HPV vaccination. |
|
| Group II (video narratives) | Experimental | Participants receive video narratives about HPV vaccination. |
|
| Group III (written narratives) | Experimental | Participants receive written narratives about HPV vaccination. |
|
| Group IV (enhanced access to vaccine, CDC information) | Experimental | Participants receive enhanced access to vaccination and standard CDC information about HPV vaccination. |
|
| Group V (enhanced access to vaccine, video narratives) | Experimental |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Enhancing Accessibility to Health Care | Other | Receive enhanced access to vaccination |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of human papillomavirus (HPV) vaccination initiation | At 3 months | |
| Rate of HPV vaccination completion | At 9 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Qian Lu, MD,PHD | M.D. Anderson Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38840086 | Derived | Lu Q, Dawkins-Moultin L, Cho D, Tan NQP, Hopfer S, Li Y, Ramondetta L, Xu Y, Lun D, Chen M. A multilevel intervention to promote HPV vaccination among young adults in Texas: protocol for a randomized controlled trial. BMC Public Health. 2024 Jun 5;24(1):1506. doi: 10.1186/s12889-024-18828-9. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D030361 | Papillomavirus Infections |
| ID | Term |
|---|---|
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D007407 | Interviews as Topic |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Participants receive enhanced access to vaccination and video narratives about HPV vaccination.
|
| Group VI (enhanced access to vaccine, written narratives) | Experimental | Participants receive enhanced access to vaccination and written narratives about HPV vaccination. |
|
| Informational Intervention | Other | Receive standard CDC information |
|
| Informational Intervention | Other | Receive video narratives |
|
| Informational Intervention | Other | Receive written narratives |
|
| Interview | Other | Ancillary studies |
|
| Questionnaire Administration | Other | Ancillary studies |
|
| D004266 | DNA Virus Infections |
| D014777 | Virus Diseases |
| D014412 | Tumor Virus Infections |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |